Natera Gross Profit 2014-2024 | NTRA

Natera annual/quarterly gross profit history and growth rate from 2014 to 2024. Gross profit can be defined as the profit a company makes after deducting the variable costs directly associated with making and selling its products or providing its services.
  • Natera gross profit for the quarter ending September 30, 2024 was $0.272B, a 124.59% increase year-over-year.
  • Natera gross profit for the twelve months ending September 30, 2024 was $0.883B, a 108.91% increase year-over-year.
  • Natera annual gross profit for 2023 was $0.493B, a 35.38% increase from 2022.
  • Natera annual gross profit for 2022 was $0.364B, a 18.53% increase from 2021.
  • Natera annual gross profit for 2021 was $0.307B, a 63.87% increase from 2020.
Natera Annual Gross Profit
(Millions of US $)
2023 $493
2022 $364
2021 $307
2020 $187
2019 $127
2018 $92
2017 $70
2016 $77
2015 $78
2014 $81
2013 $18
Natera Quarterly Gross Profit
(Millions of US $)
2024-09-30 $272
2024-06-30 $243
2024-03-31 $209
2023-12-31 $160
2023-09-30 $121
2023-06-30 $118
2023-03-31 $94
2022-12-31 $90
2022-09-30 $94
2022-06-30 $89
2022-03-31 $91
2021-12-31 $79
2021-09-30 $77
2021-06-30 $66
2021-03-31 $86
2020-12-31 $52
2020-09-30 $46
2020-06-30 $40
2020-03-31 $49
2019-12-31 $39
2019-09-30 $34
2019-06-30 $31
2019-03-31 $24
2018-12-31 $24
2018-09-30 $24
2018-06-30 $22
2018-03-31 $22
2017-12-31 $15
2017-09-30 $21
2017-06-30 $18
2017-03-31 $16
2016-12-31 $7
2016-09-30 $20
2016-06-30 $21
2016-03-31 $30
2015-12-31 $21
2015-09-30 $14
2015-06-30 $19
2015-03-31 $23
2014-12-31
2014-09-30 $25
2014-06-30 $17
2013-12-31
Sector Industry Market Cap Revenue
Medical Medical Services $21.401B $1.083B
Natera, Inc. offers genetic testing and diagnostics with proprietary bioinformatics and molecular technology. Natera, Inc. is headquartered in San Carlos, California.
Stock Name Country Market Cap PE Ratio
Elevance Health (ELV) United States $91.424B 11.34
Cencora (COR) United States $47.484B 17.51
DiDi Global (DIDIY) China $23.330B 0.00
ICON (ICLR) Ireland $16.136B 14.37
Viatris (VTRS) United States $15.576B 4.80
Avantor (AVTR) United States $13.422B 20.12
Revvity (RVTY) United States $13.376B 23.24
CochLear (CHEOY) Australia $12.844B 0.00
BioMerieux (BMXMF) France $12.666B 0.00
Solventum (SOLV) United States $11.583B 0.00
Medpace Holdings (MEDP) United States $9.789B 27.58
Doximity (DOCS) United States $9.620B 56.63
Charles River Laboratories (CRL) United States $9.516B 18.39
HealthEquity (HQY) United States $8.966B 48.66
Sonic Healthcare (SKHHY) Australia $8.758B 0.00
Bausch + Lomb (BLCO) Canada $6.885B 32.05
Life Times (LTH) United States $5.085B 33.66
Sotera Health (SHC) United States $3.855B 20.62
Organon (OGN) United States $3.757B 3.79
BrightSpring Health Services (BTSG) United States $3.247B 69.07
Surgery Partners (SGRY) United States $2.892B 32.97
PACS (PACS) United States $2.606B 0.00
Concentras Parent (CON) United States $2.581B 0.00
Ardent Health Partners (ARDT) United States $2.375B 0.00
Premier (PINC) United States $2.143B 11.15
Alignment Healthcare (ALHC) United States $2.126B 0.00
Ryman Healthcare (RYHTY) New Zealand $2.036B 0.00
GeneDx Holdings (WGS) United States $1.952B 0.00
GoodRx Holdings (GDRX) United States $1.616B 42.40
Teladoc Health (TDOC) United States $1.537B 0.00
Pediatrix Medical (MD) United States $1.255B 12.28
CareDx (CDNA) United States $1.183B 0.00
Progyny (PGNY) United States $1.164B 23.57
Establishment Labs Holdings (ESTA) $1.050B 0.00
AMN Healthcare Services Inc (AMN) United States $0.954B 6.46
QDM (QDMI) Hong Kong, SAR China $0.790B 20.69
Embecta (EMBC) United States $0.778B 5.18
SBC Medicals (SBC) United States $0.677B 0.00
Agilon Health (AGL) United States $0.655B 0.00
InnovAge Holding (INNV) United States $0.647B 0.00
Auna S.A (AUNA) Luxembourg $0.536B 0.00
Sonida Senior Living (SNDA) United States $0.425B 0.00
DocGo (DCGO) United States $0.410B 15.46
Enhabit (EHAB) United States $0.366B 31.61
COMPASS Pathways (CMPS) United Kingdom $0.326B 0.00
LifeMD (LFMD) United States $0.241B 0.00
ModivCare (MODV) United States $0.223B 12.09
Sera Prognostics (SERA) United States $0.209B 0.00
Beauty Health (SKIN) United States $0.200B 0.00
Biodesix (BDSX) United States $0.180B 0.00
Nutex Health (NUTX) United States $0.156B 0.00
Ascend Wellness Holdings (AAWH) United States $0.100B 0.00
So-Young (SY) China $0.092B 22.25
MultiPlan (MPLN) United States $0.084B 0.00
Singular Genomics Systems (OMIC) United States $0.054B 0.00
OncoCyte (OCX) United States $0.043B 0.00
NeueHealth (NEUE) United States $0.041B 1.08
Co-Diagnostics (CODX) United States $0.034B 0.00
Pheton Holdings (PTHL) China $0.030B 0.00
IceCure Medical (ICCM) Israel $0.028B 0.00
NeuroOne Medical Technologies (NMTC) United States $0.020B 0.00
Oncology Institute (TOI) United States $0.014B 0.00
SeaStar Medical Holding (ICU) United States $0.009B 0.00
XWELL (XWEL) United States $0.008B 0.00
Intelligent Bio Solutions (INBS) United States $0.006B 0.00
BioNexus Gene Lab (BGLC) $0.005B 0.00
KindlyMD (KDLY) United States $0.005B 0.00
ISpecimen (ISPC) United States $0.004B 0.00
NewGenIvf Group (NIVF) Thailand $0.002B 0.00
Aclarion (ACON) United States $0.002B 0.00
Cano Health (CANOQ) United States $0.001B 0.00